نتائج البحث

The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated Pediatric Influenza Patients during Two Influenza Seasons after the COVID-19 Pandemic: The Impact of Comorbidities on Hospitalization for Influenza in Children.

• Authors : Jugulete G; Faculty of Medicine, University of Medicine and Pharmacy, 'Carol Davila', No. 37, Dionisie Lupu Street, 2nd District, 020021 Bucharest, Romania.; 'Matei Balş' National Institute for Infectious Diseases, No. 1, Calistrat Grozovici Street, 2nd District, 021105 Bucharest, Romania.

Subjects: Oseltamivir*/Oseltamivir*/Oseltamivir*/therapeutic use ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; Influenza, Human*/Influenza, Human*/Influenza, Human*/epidemiology

• Source: Viruses [Viruses] 2024 Oct 07; Vol. 16 (10). Date of Electronic Publication: 2024 Oct 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.

• Authors : Akram J; Vice Chancellor/Professor of Internal Medicine, University of Health Sciences, Lahore, Pakistan.; Azhar S

Subjects: Azithromycin*/Azithromycin*/Azithromycin*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19 Drug Treatment*

• Source: Trials [Trials] 2020 Aug 08; Vol. 21 (1), pp. 702. Date of Electronic Publication: 2020 Aug 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

Development of UPLC method for simultaneous assay of some COVID-19 drugs utilizing novel instrumental standard addition and factorial design.

• Authors : El-Shorbagy HI; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522, Egypt. .; Mohamed MA

Subjects: Oseltamivir* ; COVID-19*; Humans

• Source: Scientific reports [Sci Rep] 2023 Apr 04; Vol. 13 (1), pp. 5466. Date of Electronic Publication: 2023 Apr 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19

• Authors : Sara Samir Mohamed Elmenshawy; Mohamed Farouk Ahmed Abdelsalam; Tarek Refaat El Nagdy

Subjects: Coronavirus disease 2019; COVID-19; CT-scan

• Source: Future Science OA, Vol 10, Iss 1 (2024)

تفاصيل العنوان

IMU-838 and Oseltamivir in the Treatment of COVID-19 (IONIC)

• Authors : Immunic AG; University of Warwick; MODEPHARMA

• Source: Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination With Oseltamivir, in Adults With

تفاصيل العنوان

Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19).

• Authors : Aliyu, Basiru^1,2 (AUTHOR); Raji, Yakubu Egigogo^1,3 (AUTHOR); Chee, Hui-Yee¹ (AUTHOR)

Subjects: *CORONAVIRUS disease treatment; *COVID-19; *OSELTAMIVIR

• Source: PLoS ONE. 12/1/2022, Vol. 17 Issue 12, p1-21. 21p.

تفاصيل العنوان

Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.

• Authors : de Oliveira Formiga R; Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Brazil.; Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France.

Subjects: COVID-19* ; Sepsis*/Sepsis*/Sepsis*/chemically induced; Humans

• Source: British journal of pharmacology [Br J Pharmacol] 2023 Jun; Vol. 180 (11), pp. 1460-1481. Date of Electronic Publication: 2023 Jan 13.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

تفاصيل العنوان

Therapeutic Targeting of Inflammation and Virus Simultaneously Ameliorates Influenza Pneumonia and Protects from Morbidity and Mortality.

• Authors : Pandey P; Viral Immunology and Immunopathology Group, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS 7000, Australia.; Al Rumaih Z

Subjects: Influenza, Human*/Influenza, Human*/Influenza, Human*/complications ; Influenza, Human*/Influenza, Human*/Influenza, Human*/drug therapy ; COVID-19*

• Source: Viruses [Viruses] 2023 Jan 23; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

• Authors : Ohoud Aljuhani; Ghazwa B. Korayem; Ali F. Altebainawi

Subjects: COVID-19; Viral clearance; Oseltamivir

• Source: Saudi Pharmaceutical Journal, Vol 31, Iss 7, Pp 1210-1218 (2023)

تفاصيل العنوان

Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT (PROTECT)

• Authors : Shehnoor Azhar, Study Coordinator

• Source: Pakistan Randomized and Observational Trial to Evaluate Coronavirus TreatmentAzhar S, Akram J, Shahzad M, Latif W, Khan KS. Protocol of Pakistan randomized and observational trial to evaluate

تفاصيل العنوان